/AGL
AGL Stock - Agilon Health, Inc.
Healthcare|Medical - Care FacilitiesNYSE
$0.73+5.11%
+$0.04 (+5.11%) • Dec 19
70
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.18
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+104.2%upside
Target: $1.50
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for AGL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$0.73 – $0.74
TARGET (TP)$1.50
STOP LOSS$0.68
RISK/REWARD1:14.0
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.07
52W High$6.08
52W Low$0.51
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $6.06B | $4.32B | $2.39B | $1.52B | $1.22B |
| Gross Profit | $4.84M | $69.67M | $111.36M | $65.74M | $94.15M |
| Gross Margin | 0.1% | 1.6% | 4.7% | 4.3% | 7.7% |
| Operating Income | $-292,130,000 | $-232,133,000 | $-105,378,000 | $-372,242,000 | $-56,673,000 |
| Net Income | $-260,151,000 | $-262,596,000 | $-106,553,000 | $-406,487,000 | $-60,052,000 |
| Net Margin | -4.3% | -6.1% | -4.5% | -26.7% | -4.9% |
| EPS | $-0.63 | $-0.64 | $-0.26 | $-1.09 | $-0.16 |
Company Overview
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
8
35%
Hold / Neutral
13
57%
Sell / Underperform
2
9%
Analyst Consensus🔴 Bearish
8 Bullish15 Neutral/Bearish
Price Targets
$12
Average Target
↑ 1579.0% Upside
Now
$1
Low
$12
Average
$38
High
Based on 23 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 20th 2025 | Bernstein | Downgrade | Market Perform | $1.4 |
| August 6th 2025 | Citigroup | Downgrade | Neutral | $1 |
| April 25th 2025 | Citigroup | Upgrade | Buy | $5 |
| April 8th 2025 | Bernstein | Upgrade | Outperform | $8.5 |
| January 10th 2025 | Needham | Initiation | Hold | - |
| January 10th 2025 | Citigroup | Upgrade | Neutral | $2.25← $1.75 |
| December 16th 2024 | Macquarie | Initiation | Neutral | - |
| December 11th 2024 | Bernstein | Initiation | Market Perform | $2.5 |
| November 11th 2024 | JMP Securities | Downgrade | Market Perform | - |
| November 8th 2024 | William Blair | Downgrade | Market Perform | - |
| October 30th 2024 | Citigroup | Downgrade | Sell | $2.5← $7 |
| October 2nd 2024 | BofA Securities | Downgrade | Underperform | $3 |
| May 30th 2024 | Robert W. Baird | Initiation | Neutral | $6 |
| April 22nd 2024 | Citigroup | Initiation | Neutral | $6 |
| March 6th 2024 | Barclays | Initiation | Underweight | $5 |
Earnings History & Surprises
AGLBeat Rate
18%
Last 17 quarters
Avg Surprise
-19.7%
EPS vs Estimate
Beats / Misses
3/13
1 met exactly
Latest EPS
$-0.27
Q4 2025
EPS Surprise History
Q1 24
-46.4%
$-0.41vs$-0.28
Q2 24
+17.8%
$0.01vs$0.01
Q3 24
0.0%
$-0.07vs$-0.07
Q4 24
-190.0%
$-0.29vs$-0.10
Q1 25
-38.9%
$-0.25vs$-0.18
Q2 25
+400.0%
$0.03vs$-0.01
Q3 25
-127.3%
$-0.25vs$-0.11
Q4 25
-50.0%
$-0.27vs$-0.18
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 4, 2026 | — | — | — | — |
Q1 2026 | Feb 24, 2026 | $-0.27 | — | — | — |
Q4 2025 | Nov 4, 2025 | $-0.18 | $-0.27 | -50.0% | ✗ MISS |
Q3 2025 | Aug 4, 2025 | $-0.11 | $-0.25 | -127.3% | ✗ MISS |
Q2 2025 | May 6, 2025 | $-0.01 | $0.03 | +400.0% | ✓ BEAT |
Q1 2025 | Feb 25, 2025 | $-0.18 | $-0.25 | -38.9% | ✗ MISS |
Q4 2024 | Nov 7, 2024 | $-0.10 | $-0.29 | -190.0% | ✗ MISS |
Q3 2024 | Aug 6, 2024 | $-0.07 | $-0.07 | 0.0% | = MET |
Q2 2024 | May 7, 2024 | $0.01 | $0.01 | +17.8% | ✓ BEAT |
Q1 2024 | Feb 27, 2024 | $-0.28 | $-0.41 | -46.4% | ✗ MISS |
Q4 2023 | Nov 2, 2023 | $-0.05 | $-0.06 | -20.0% | ✗ MISS |
Q3 2023 | Aug 3, 2023 | $-0.03 | $-0.04 | -57.6% | ✗ MISS |
Q2 2023 | May 9, 2023 | $0.02 | $0.04 | +135.3% | ✓ BEAT |
Q1 2023 | Mar 1, 2023 | $-0.08 | $-0.14 | -75.0% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $-0.05 | $-0.07 | -40.0% | ✗ MISS |
Q3 2022 | Aug 4, 2022 | $-0.01 | $-0.04 | -177.8% | ✗ MISS |
Q2 2022 | May 5, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 3, 2022 | $-0.12 | $-0.14 | -16.7% | ✗ MISS |
Q4 2021 | Oct 28, 2021 | $-0.07 | $-0.09 | -28.6% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $-0.05 | $-0.06 | -20.0% | ✗ MISS |
Latest News
agilon health Receives Notice Of Non-Compliance From NYSE; Co Intends To Seek Shareholder Approval For Reverse Stock Split
📉 NegativeBenzinga•Nov 7, 2025, 12:03 PM
Barclays Maintains Underweight on Agilon Health, Lowers Price Target to $1
📉 NegativeBenzinga•Nov 6, 2025, 02:25 PM•Also:
Wells Fargo Maintains Overweight on Agilon Health, Lowers Price Target to $1
➖ NeutralBenzinga•Nov 5, 2025, 03:08 PM
Agilon Health Lowers FY2025 Sales Guidance from $5.850B-$6.025B to $5.810B-$5.830B vs $5.815B Est
📉 NegativeBenzinga•Nov 4, 2025, 09:18 PM
Agilon Health Q3 EPS $(0.27) Misses $(0.16) Estimate, Sales $1.435B Beat $1.423B Estimate
➖ NeutralBenzinga•Nov 4, 2025, 09:13 PM
Wells Fargo Maintains Overweight on Agilon Health, Lowers Price Target to $1.5
📉 NegativeBenzinga•Oct 7, 2025, 02:10 PM
Bernstein Downgrades Agilon Health to Market Perform, Lowers Price Target to $1.4
📉 NegativeBenzinga•Aug 20, 2025, 11:08 AM•Also:
Frequently Asked Questions about AGL
What is AGL's current stock price?
Agilon Health, Inc. (AGL) is currently trading at $0.73 per share. The stock has moved +5.11% today.
What is the analyst price target for AGL?
The average analyst price target for AGL is $1.50, based on 1 analyst.
What sector is Agilon Health, Inc. in?
Agilon Health, Inc. operates in the Healthcare sector, specifically within the Medical - Care Facilities industry. The company is traded on the NYSE exchange.
What is AGL's market cap?
Agilon Health, Inc. has a market capitalization of $0.30 billion, making it a small-cap company.
Does AGL pay dividends?
No, Agilon Health, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorANNX
Annexon, Inc.
$5.17
Mkt Cap: $0.6B
DBVT
DBV Technologies S.A.
$22.76
Mkt Cap: $0.5B
DH
Definitive Healthcare Corp.
$2.54
Mkt Cap: $0.3B
EHAB
Enhabit, Inc.
$9.56
Mkt Cap: $0.5B
ENGN
enGene Holdings Inc.
$8.69
Mkt Cap: $0.4B
LRMR
Larimar Therapeutics, Inc.
$3.65
Mkt Cap: $0.3B
MCTA
Charming Medical Limited Class A Ordinary Shares
$29.36
Mkt Cap: $0.4B
NAKA
Kindly MD, Inc.
$0.39
Mkt Cap: $0.1B
SLP
Simulations Plus, Inc.
$18.75
Mkt Cap: $0.4B
SOPH
SOPHiA GENETICS S.A.
$4.61
Mkt Cap: $0.3B
Explore stocks similar to AGL for comparison